newsJun 24, 202519:49pending
FDA APPROVES MERCK’S RSV SHOT DESPITE ALARMING INFANT TRIAL DATA
About this episode
Del and Jefferey dive into the troubling numbers behind Merck’s new RSV shot for infants, recently greenlit by the FDA. Trial data revealed higher rates of deaths and severe respiratory illness in vaccinated babies, yet the FDA overlooked this concerning trial data.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
Get every episode summarized
Each time The Highwire with Del Bigtree publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Highwire with Del Bigtree
Episode 472: RFK JR.’S ACIP REWRITE, GLYPHOSATE SHOWDOWN, THE SCIENCE OF HOMEOPA...
The Highwire with Del Bigtree
Apr 17, 20261:42:17failed
Episode 471: CLIMATE LOCKDOWNS, AI EXPANSION, AND COVID VACCINE INJURY
The Highwire with Del Bigtree
Apr 9, 20261:43:08failed
Episode 470: A FOOD CRISIS, AUTISM COMMUNICATION RIGHTS, AND STEM CELL SECRETS
The Highwire with Del Bigtree
Apr 3, 20261:59:37failed
Episode 469: ACIP UPHEAVAL, AI DISRUPTION, AND MASTERING YOUR MIND
The Highwire with Del Bigtree
Mar 26, 20262:27:27failed